Quick Answer
BIOMERICA INC reported R&D Expense of $1.02 million for fiscal year 2025.
BIOMERICA INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.02M | -31.4% |
| 2024 | $1.49M | -5.9% |
| 2023 | $1.58M | -12.6% |
| 2022 | $1.81M | -17.4% |
| 2021 | $2.19M | +14.9% |
| 2020 | $1.91M | +13.8% |
| 2019 | $1.68M | +20.1% |
| 2018 | $1.40M | +23.7% |
| 2017 | $1.13M | +44.9% |
| 2016 | $780.3K | +6.4% |
| 2015 | $733.6K | +24.4% |
| 2014 | $589.9K | +28.5% |
| 2013 | $459.1K | +32.3% |
| 2012 | $347.1K | -17.5% |
| 2011 | $420.6K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $193.0K | -24.9% | -9.0% |
| August 31, 2025 | $212.0K | -28.6% | -2.3% |
| February 28, 2025 | $217.0K | -36.7% | -15.6% |
| November 30, 2024 | $257.0K | -37.6% | -13.5% |
| August 31, 2024 | $297.0K | -37.1% | -13.4% |
| February 29, 2024 | $343.0K | -12.5% | -16.7% |
| November 30, 2023 | $412.0K | -10.8% | -12.7% |
| August 31, 2023 | $472.0K | +30.7% | +20.4% |
- BIOMERICA INC showed a decrease of -31.4% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2025 period, BIOMERICA INC’s r&d expense has grown by 143.2% (from $420.6 thousand to $1.02 million).
- The most recent figure is from BIOMERICA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: